MedPath

The Efficacy and Safety of Non-resistance Manual Therapy in Inpatients With Acute Neck Pain Caused by Traffic Accidents: a Randomised Controlled Trial

Not Applicable
Completed
Conditions
Whiplash Injury of Cervical Spine
Interventions
Other: acupuncture
Other: non-resistance therapy
Other: chuna
Other: pharmacoacupuncture
Drug: Korean herbal medicine
Registration Number
NCT04660175
Lead Sponsor
Jaseng Medical Foundation
Brief Summary

Non-resistance therapy is a combination of muscle compression relaxation technique and joint mobilization in patients with acute neck pain caused by traffic accidents. This study is to evaluate the effectiveness and safety of non-resistance therapy for pain and function problems in patients complaining of acute neck pain induced by traffic accidents.

So, investigators conduct a randomized controlled trials to verify the effectiveness and safety of non-resistance therapy. From December 2020 to May 2021, investigators recruit 120 inpatients who are suffered from acute neck pain with the numeric rating scale(NRS) over 5 by traffic accident(TA).

The Korean medical treatment group(n=60) receives daily acupuncture, herbal medicine, and chuna treatment as inpatient treatment from hospitalization until discharge. For the non-resistance therapy group(n=60), the korean medical treatment is performed in the same manner, but additional non-resistance therapy is performed once a day from the 2nd day to the 5th day of hospitalization.

Baseline is the time point before treatment for non-resistance therapy on the second day of hospitalization, and the primary endpoint is the time point after treatment on the 5th day (v5) after hospitalization.

For these two groups, investigators compare NRS(Numeric Rating Scale), Visual Analogue Scale(VAS), Range Of Motion(ROM), Neck Disability Index(NDI), the 12-Item Short Form Health Survey(SF-12), and PTSD Checklist for DSM(Diagnostic and Statistical Manual of Mental Disorders, DSM)-5(PCL-5).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Patients aged 19-70 years on the date they sign the consent form
  • Patients with NRS ≥ 5 for neck pain
  • Patients who needs hospitalization due to acute neck pain that occurred within 7 days after traffic accident
  • Patients who provide consent to participate in the trial and return the informed consent form
Exclusion Criteria
  • Patients with a specific serious disease that may cause acute neck pain: malignancy, fracture of lumbar spine, etc.
  • Patients with progressive neurological deficits or with severe neurological symptoms
  • The cause of pain is due to soft tissue disease, not the spine: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
  • Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
  • Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
  • Patients who are pregnant, planning to become pregnant, or are breastfeeding
  • Patients who have had surgery or procedures of cervical spine within the last three weeks
  • Patients with a serious mental illness
  • Patients who has not passed one month since the end of participation in other clinical studies, or plan to participate in other clinical studies during the study participation and follow-up period within 12 weeks
  • Patients who are difficult to complete the research participation agreement
  • Other patients whose participation in the trial is judged by a researcher to be problematic

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non-resistance therapypharmacoacupunctureFrom the 2nd to 5th day of hospitalization, once a day, 4 times of non-resistance therapy is administered. And non-resistance therapy group is also treated with other Korean integrative medicine treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Non-resistance therapyKorean herbal medicineFrom the 2nd to 5th day of hospitalization, once a day, 4 times of non-resistance therapy is administered. And non-resistance therapy group is also treated with other Korean integrative medicine treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Oriental medicine integrated treatmentacupunctureThe control group is received Korean integrative medicine treatment everyday; acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Oriental medicine integrated treatmentchunaThe control group is received Korean integrative medicine treatment everyday; acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Oriental medicine integrated treatmentpharmacoacupunctureThe control group is received Korean integrative medicine treatment everyday; acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Oriental medicine integrated treatmentKorean herbal medicineThe control group is received Korean integrative medicine treatment everyday; acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Non-resistance therapynon-resistance therapyFrom the 2nd to 5th day of hospitalization, once a day, 4 times of non-resistance therapy is administered. And non-resistance therapy group is also treated with other Korean integrative medicine treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Non-resistance therapyacupunctureFrom the 2nd to 5th day of hospitalization, once a day, 4 times of non-resistance therapy is administered. And non-resistance therapy group is also treated with other Korean integrative medicine treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Non-resistance therapychunaFrom the 2nd to 5th day of hospitalization, once a day, 4 times of non-resistance therapy is administered. And non-resistance therapy group is also treated with other Korean integrative medicine treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Primary Outcome Measures
NameTimeMethod
Numeric Rating Scale(NRS) of neck painChange from baseline NRS at 5 days

The extent of acute neck pain and discomfort was assessed using NRS. NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participants are asked to report their neck pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

Secondary Outcome Measures
NameTimeMethod
Range of movement (ROM) of extensionbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

Range of movement (ROM) of extension is measured.

Visual Analogue Scale (VAS) of neck painbaseline(day2), day3, day4, day5, day of Discharge(up to 14days

VAS is an assessment index in which the patient records their pain on a 100mm line from 'no pain' at one end, and 'the most severe pain imaginable' at the other end.

Range of movement (ROM) of left rotationbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

Range of movement (ROM) of left rotation is measured.

Range of movement (ROM) of right rotationbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

Range of movement (ROM) of right rotation is measured.

Numeric Rating Scale(NRS) of neck painbaseline(day2), day3, day4, day5, day of Discharge(up to 14days), week 12

NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participants are asked to report their neck pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'

Visual Analogue Scale (VAS) of arm painbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

VAS is an assessment index in which the patient records their pain on a 100mm line from 'no pain' at one end, and 'the most severe pain imaginable' at the other end.

Range of movement (ROM) of flexionbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

Range of movement (ROM) of flexion is measured.

Range of movement (ROM) of right lateral flexionbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

Range of movement (ROM) of right lateral flexion is measured.

Neck Disability Index (NDI)baseline(day2), day5, day of Discharge(up to 14days), week 12

Functional disability questionnaire. The possible range of each item score is 0 to 5. Total score range: 0 (better outcome) to 100 (worse outcome)

Patient Global Impression of Change (PGIC)day5, day of Discharge(up to 14days), week 12

The PGIC is an index that assesses improvements in functional limitation caused by whiplash injury. Participants rate the improvement in functional limitations after treatment on a 7-point Likert scale (1=Very much improved, 4=No change, 7=Very much worse). This index was originally developed for use in Psychology, but is currently used in various other medical fields to assess improvements in pain.

Drug Consumptionbaseline(day2), day3, day4, day5, day of Discharge(up to 14days), week 12

During the study period, the type and dose of drugs (prescribed due to the current medical history or remedy) were observed through a questionnaire when visiting the study subjects.

Adverse eventsbaseline(day2), day3, day4, day5, day of Discharge(up to 14days), week 12

Safety outcome

Range of movement (ROM) of left lateral flexionbaseline(day2), day3, day4, day5, day of Discharge(up to 14days)

Range of movement (ROM) of left lateral flexion is measured.

Korean version of The Posttraumatic Stress Disorder Checklist for DSM-5(PCL-5-K)baseline(day 2), day5, day of Discharge(up to 14days), week 12

The PCL-5(The Posttraumatic Stress Disorder Checklist for DSM-5) is a 20-item, 5-point-Likert-scale, self-report questionnaire to measure the PTSD symptoms in the DSM-536 and to diagnose PTSD. A higher score (out of 80) indicates severe PTSD.

Numeric Rating Scale(NRS) of arm painbaseline(day2), day3, day4, day5, day of Discharge(up to 14days), week 12

NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10.

12-item Short-Form Health Survey (SF-12)baseline(day 2), day5, day of Discharge(up to 14days), week 12

The SF-12 is a shortened version of the Short Form-36 Health Survey (SF-36), which is a widely used instrument to assess health-related quality of life. The SF-12 consists of 12 questions across 8 domains, and higher scores indicate better health-related quality of life.

Credibility and Expectancybaseline(day 2)

Credibility and Expectancy is a 9-point scale-likert-scale to evaluate the participants' expectations for treatment.(1 = not at all, 5 = somewhat, and 9 = very much)

Trial Locations

Locations (1)

Daejeon Jaseng Hospital of Korean Medicine

🇰🇷

Daejeon, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath